Abstract:Human angiotensin-I-converting enzyme (ACE) is an important target of antihypertensive therapy, which possesses a bulky, hydrophobic pocket that is physicochemically compatible with a wide variety of peptide substrates and small-molecule ligands. Rational design of potent ACE inhibitors has long been an attractive topic in the chemical, biological and medical communities. In the present study, an integrative protocol is described to optimize and modify peptides bound with ACE based on their complex three-dimensional structures. The protocol combines a number of sophisticated computational methods including molecular dynamics (MD) simulation, quantitative structure-activity relationship (QSAR), molecular mechanics/Poisson-Boltzmann surface area (MM-PB/SA) and quantum mechanics/molecular mechanics (QM/MM) to discover new potent ACE-inhibitory peptides. With this strategy hundreds of potential peptides are generated virtually, from which several promising candidates are synthesized and assayed in vitro using a standard Fmoc-protected amino acid solid phase synthesis and spectrophotometric method, respectively. Six peptides are found to have potency against ACE, four of which (LVY, VLKP, MLPVY and LKIPLY) show satisfactory inhibitory capability (pIC(50)=5.84, 5.27, 5.40 and 5.57, respectively). Subsequently, the complex structures of tripeptide LVY and hexapeptide LKIPLY with ACE are computationally modeled and their binding free energies are estimated as -34.2 and -57.8 kcal/mol, respectively, by using a rigorous QM/MM scheme. Intensive steric collisions are observed around the C-terminus of peptide ligands in the bound state. Based upon the findings the C-terminal residues of the two peptides are modified to small, hydrophobic amino acids Val and Ala, resulting in mutated peptides LVA and LKIPVA, respectively. Consequently, a significant improvement in ACE inhibitory activity is observed for the LKIPVA mutant (pIC(50) increases from 5.57 to 6.07), whereas only a modest activity change was associated with the LVA mutant (pIC(50) decreases from 5.84 to 5.80).

Angiotensin Converting Enzyme (ACE)-Peptide Interactions: Inhibition Kinetics, In Silico Molecular Docking and Stability Study of Three Novel Peptides Generated from Palm Kernel Cake Proteins

Purification, Characterization, Synthesis, in Vitro ACE Inhibition and in Vivo Antihypertensive Activity of Bioactive Peptides Derived from Oil Palm Kernel Glutelin-2 Hydrolysates

Optimisation and Characterisation of Novel Angiotensin-Converting Enzyme Inhibitory Peptides Prepared by Double Enzymatic Hydrolysis from Agaricus bisporus Scraps

Novel Angiotensin I-converting Enzyme Inhibitory Peptides from Protease Hydrolysates of Qula Casein: Quantitative Structure-Activity Relationship Modeling and Molecular Docking Study

Quantitative Structure-Activity Relationship Modeling Coupled with Molecular Docking Analysis in Screening of Angiotensin I-Converting Enzyme Inhibitory Peptides from Qula Casein Hydrolysates Obtained by Two-Enzyme Combination Hydrolysis.

Integrating Computational Modeling and Experimental Assay to Discover New Potent Ace-Inhibitory Peptides

Enzyme Inhibition Kinetics and Molecular Interactions of Patatin Peptides with Angiotensin I-converting Enzyme and Renin.

Interactions of C. Frondosa-Derived Inhibitory Peptides Against Angiotensin I-converting Enzyme (ACE), Α-Amylase and Lipase.

Computational exploration of naturally derived peptides inhibitory mechanisms against ACE enzyme, from interactions to structural-dynamics

Identification of Bioactive Peptides from a Laminaria digitata Protein Hydrolysate Using In Silico and In Vitro Methods to Identify Angiotensin-1-Converting Enzyme (ACE-1) Inhibitory Peptides

Purification and Molecular Docking Study on the Angiotensin I-Converting Enzyme (ACE)-Inhibitory Peptide Isolated from Hydrolysates of the Deep-Sea Mussel Gigantidas vrijenhoeki

Microwave-Assisted Solid-Phase Synthesis, Biological Evaluation and Molecular Docking of Angiotensin I-Converting Enzyme Inhibitors

Structural requirements of Angiotensin I-converting enzyme inhibitory peptides: quantitative structure-activity relationship study of di- and tripeptides

The novel angiotensin-I-converting enzyme inhibitory peptides from Scomber japonicus muscle protein hydrolysates: QSAR-based screening, molecular docking, kinetic and stability studies

Improving efficiency of an angiotensin converting enzyme inhibitory peptide as multifunctional peptides

Analysis And Evaluation Of The Inhibitory Mechanism Of A Novel Angiotensin-I-Converting Enzyme Inhibitory Peptide Derived From Casein Hydrolysate

Novel ACE Inhibitory Peptides Derived from Whey Protein Hydrolysates: Identification and Molecular Docking Analysis

Identification, Screening and Molecular Mechanisms of Natural Stable Angiotensin-Converting Enzyme (ACE) Inhibitory Peptides from Foxtail Millet Protein Hydrolysates: a Combined in Silico and in Vitro Study.

Value-added Utilization of Yak Milk Casein for the Production of Angiotensin-I-converting Enzyme Inhibitory Peptides

Studies on the Bioactivities of ACE-inhibitory Peptides with Phenylalanine C-terminus Using 3D-QSAR, Molecular Docking and in Vitro Evaluation.

Interaction Mechanisms of ACE Inhibitory Peptides: Molecular Docking and Molecular Dynamics Simulation Studies on Five Wheat Gluten Derived Peptides